The film presents a detailed fluorographic study of the normal heart using venous catheterization, showcasing physiological data such as pressure and flow measurements. It illustrates blood flow ...

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.

Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...

Arrhythmogenic right ventricular cardiomyopathy, or ARVC, is a heart condition caused by a small mutation in a person's genetic code.

Longeveron (LGVN) announced the publication in Nature Medicine of results from the CLEAR MIND Phase 2a clinical trial evaluating laromestrocel ...

A young girl from Niskayuna, born with seven heart defects, is preparing for another surgery this year. Her family is ...

New Mayo Clinic research connects energy drinks to cardiac emergencies in people with heart conditions. Learn who's at risk ...

Heart disease is a relatively common condition in dogs, especially in older dogs. In fact, it is estimated that approximately ...

The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial ...

Even modern cancer treatments appear risky for the heart, especially if the radiation dose to the LAD is high.

A scientific statement regarding clinical considerations for athletes with cardiovascular abnormalities has been published by the AHA and ACC.

Phase 2a results demonstrated laromestrocel (Lomecel-B) improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer's diseaseThis encouraging clinical trial data ...